Form 8-K MYRIAD GENETICS INC For: Feb 07

Go back to Form 8-K MYRIAD GENETICS INC For: Feb 07

Ladenburg Thalmann Upgrades Myriad Genetics (MYGN) to Neutral

February 8, 2017 6:42 AM EST

Ladenburg Thalmann upgraded Myriad Genetics (NASDAQ: MYGN) from Sell to Neutral.

For an analyst ratings summary and ratings history on Myriad Genetics click here. For more ratings news on Myriad Genetics click here.

Shares of Myriad Genetics closed at $15.40 yesterday.

... More